The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and EstoniaMartí Català, Annika M. Jödicke, Hedvig Nordeng et al.|The Lancet Respiratory Medicine|2024Cited by 166
The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complicationsNúria Mercadé‐Besora, Martí Català, Xintong Li et al.|Heart|2024Cited by 50
Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort studyErica A. Voss, Rohit Vashisht, Azza Shoaibi et al.|EClinicalMedicine|2023Cited by 27
Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDISKristin Kostka, Nicole G. Weiskopf, Talita Duarte‐Salles et al.|Clinical Epidemiology|2022Cited by 26
The burden of post-acute COVID-19 symptoms in a multinational network cohort analysisKristin Kostka, Annika M. Jödicke, Elena Roel et al.|Nature Communications|2023Cited by 24